Imagine being able to test for 30+ different cancers: 🏠 at home 👨‍⚕️ without a medical professional ➡️ using only breath &/or urine samples Announcing the teams aiming to revolutionize early detection for hard to diagnose cancers for our POSEIDON program 👇 arpa-h.gov/news-and-eve...

We’re accelerating international collaborations that will enhance the impact of our initiatives on a global scale, and hosted the K-Health MIRAE initiative at our DC office, welcoming a delegation of their program managers & leadership to explore collaboration opportunities with ARPA-H counterparts.

BREATHE easy. 😮‍💨🫁 Announcing the 4 trailblazing teams for our program that aims to revolutionize public health by transforming a building’s ability to eliminate indoor air threats. Get to know our BREATHE program awardees ⬇️ arpa-h.gov/news-and-eve...

Our project with The University of Texas at Austin aims to develop technology for continuous, real-world monitoring of blood pressure, a key vital sign for assessing cardiovascular health. Learn more about the CLINAC-BP project ⬇️ arpa-h.gov/explore-fund...

Our new programs aim to revolutionize genetic medicine development and manufacturing! 1️⃣ THRIVE aims to develop affordable precision genetic medicines for all Americans 2️⃣ GIVE aims to ignite innovative biomanufacturing for cell and gene therapies Learn more: arpa-h.gov/news-and-eve...

NEW: With cutting-edge production technologies, our GIVE program seeks to establish the U.S. as a frontrunner in advanced manufacturing methods for high-quality genetic medicines. Learn how ➡️ arpa-h.gov/news-and-eve...

What if we could find treatments for rare hereditary diseases faster? We are closer than you think with the launch of our new THRIVE program! arpa-h.gov/news-and-eve...

💡 "I strongly believe we are in a moment," says @arpa-h.bsky.social's Dr. Mimi Lee, who is speaking at the 8th Annual Policy Summit NEXT WEEK in Washington, D.C.! Hear why she's excited to attend this event and make sure to register: https://bit.ly/3KaYScC #ASGCTadvocacy #rarediseases

Our project with Icahn School of Medicine at Mount Sinai aims to: 🗺️ Create a comprehensive computational map of pathogen-host interactions 💊 Uncover the best drug targets for an entire family of pathogens, instead of each individual pathogen as it’s done today (1/2)

We are thrilled to be a part of the new tech partnership with the UK, working with our partners overseas to advance bold AI solutions for health — especially for precision medicine and rare and chronic diseases. 🇺🇸 🇬🇧 www.whitehouse.gov/presidential...

Our project with Stanford aims to establish data partnerships to expand the PRIME registry (the largest primary care data registry in the U.S.) by 50%, building an enriched dataset to help clarify the social determinants of health and causal drivers of disease. (1/2)

Our project with University of North Dakota aims to develop edge computing technology to create advanced machine learning models that will predict and improve diabetes foot ulcer risk prediction and wound healing prediction for senior citizens with diabetes. arpa-h.gov/explore-fund...

The 2025 AI Cyber Challenge (#AIxCC) at DEF CON 33 showcased AI’s power to secure America’s hospitals and protect patient data. Read the recap👇 arpa-h.gov/news-and-eve...

Our project with University of Colorado Boulder intends to develop cutting-edge technologies aimed at preserving the health and function of biological tissues under urgent stress or injury conditions. Learn more: arpa-h.gov/explore-fund...

#AIxCC #DEFCON33 schedule on Friday, 8/8: ▫️11 am PT: #AIxCC Program Manager Andrew Carney provides competition debrief & announces the winners 🏆 ▫️2:40 pm PT: “From Data Security to Discovery: How ARPA-H is Using AI to Transform Health Care in America” (panel) Learn more: aicyberchallenge.com

Step into the lab at Johns Hopkins University and see our SARRTS (Supervised Autonomous Robotic Renal Tumor Surgery) project in action by observing a robot perform a demonstration of tumor removal surgery on a "phantom kidney." Learn more: arpa-h.gov/explore-fund... youtu.be/z96ZQ39aNtI?...

We’re excited to join DARPA to announce the winners of the AI Cyber Challenge (AIxCC) at #DEFCON33. Get a preview of #AIxCC from Program Manager Andrew Carney who says, “The awards are big because the stakes are high, and the challenge is massive.” arpa-h.gov/news-and-eve...

A return to independence. Current treatments for severe brain damage only restore partial function. FRONT aims to heal and repair brain tissue and enable individuals with brain damage to recover lost functions. Register for FRONT Proposers' Day on August 8 (by August 5): arpa-h.gov/explore-fund...

In the latest Vitals, we launched a bold program focused on restoring brain function called FRONT (Functional Repair of Neocortical Tissue). Plus, we’re headed back to #DEFCON to join DARPA in announcing the winners of the AI Cyber Challenge. #AIxCC More: engage.arpa-h.gov/arpa-h-launc...

Healing from within to restore brain health. From Alzheimer’s disease to traumatic brain injury, FRONT aims to revolutionize how we treat brain damage and restore cognitive function. 🧠 📅 Register by August 5 for FRONT hybrid Proposers' Day on August 8: arpa-h.gov/explore-fund...

Join Program Manager Dr. Bon Ku for a walkthrough of PARADIGM’s prototype technology. Our PARADIGM program asks, what if we could deliver advanced hospital-level care to every rural county in America? PARADIGM is just getting started and we’re excited to show you more! arpa-h.gov/explore-fund...

Program Manager Dr. Jean Hebert talks about our new FRONT program which asks, what if we could restore function to the millions of Americans with permanent brain damage to the neocortex? Learn more about FRONT: arpa-h.gov/explore-fund...

NEW: No technology currently exists to repair damaged brain tissue and fully restore lost function. FRONT aims to enable millions with what is considered permanent brain damage to regain lost functions, including motor control, vision, and speech. arpa-h.gov/news-and-eve...

We’re headed to #HopkinsontheHill today, and excited to see science in action from two project awardees! 🔹SARRTS: Supervised Autonomous Robotic Renal Tumor Surgery 🔹PAIL: PhotoAcoustic Imaging technology for diagnostic Lung assessment arpa-h.gov/explore-fund...

Attending #JPM2025? Don’t miss “The ARPA-H Advantage: Transforming Health Through Non-Dilutive Capital - Women's Health As A Case Study” today at 2:15 pm PT!

🚨 The Imaging Data Exchange (INDEX) program solution summary due date has changed to Jan 28, 2025! arpa-h.gov/research-and... Full proposals are due March 27, 2025 at 5:00 PM ET

What if we had therapies to extend healthspan and prevent the onset of age-related diseases? PROSPR Program Manager, Andrew Brack, talked with Translating Aging about building a new therapeutic industry focused on maintaining health during aging. player.captivate.fm/episode/1f42...

If you are at #JPM2025 Healthcare Week, check out the PROSPR presentation today with our Program Manager Andrew Brack at the @R42 Longevity Showcase! lu.ma/0gan7pm5

The response to our #SprintForWomensHealth shows that innovation in women’s health knows no boundaries. It’s not just the great science we're pursuing, but a different way of doing business in the government. arpa-h.gov/engage-and-t...

☎️ Calling RNA researchers to fill out this survey to inform ARPA-H investments in RNA manufacturing platforms! We aim to streamline access to affordable, high-quality, and scalable RNA manufacturing. Responses due by January 10, 2025: bit.ly/3ZwRwUQ

Heading to #PMWC25? Don’t miss “PGx is Hard to Implement,” on Feb 7. in track 1 (starting at 9 am)! pmwcintl.com/session/phar... #precisionmedicine

🚨 Last day to register for the Emerging Health Innovators Proposers’ Day! Registration closes TODAY at 12pm ET. solutions.arpa-h.gov/Events/EHI/

Starting the new year off right with the message "Dare to Invest in Women's Health" with @darebioscience.bsky.social! Thank you to everyone at @nasdaqexchange.bsky.social for the incredible event. www.nasdaq.com/events/dare-...

Happening LIVE! www.nasdaq.com/events/dare-...

Coming up! Daré Bioscience Inc. and ARPA-H are at the Nasdaq MarketSite in Times Square to close of the first trading day of the new year, “Dare to Invest in Women’s Health.” www.nasdaq.com/events/dare-...

TODAY: We are ringing in more than just the New Year! 🎊 Join ARPA-H's Director and #SprintForWomensHealth awardees as we ring Nasdaq’s first closing bell of 2025! 🥂 Watch the livestream at 3:45 pm-4:15 pm ET: www.nasdaq.com/events/dare-...

🌟 Our project with TigaTx aims to create an innovative therapy platform to fight cancer and infectious diseases by harnessing the power of engineered IgA to activate immune cells. arpa-h.gov/research-and...

Increasingly, we understand that disorders ranging from #BreastCancer to #AlzheimersDisease are associated with underlying, untreated lymphatic dysfunction. That’s why our GLIDE and LIGHT programs are so important. @bbchealth.bsky.social www.bbc.com/future/artic...

Seize the opportunity to transform health outcomes. Become an ARPA-H Program Manager. arpa-h.gov/careers/what...

Our project with SonALAsense aims to bring to market a minimally- or non-invasive treatment for blood cancers! This is about increasing efficiency, increasing patient comfort, and decreasing cost. arpa-h.gov/news-and-eve...

We appreciated the opportunity for our International Partnerships Lead, Amy Lin, to join an interagency panel discussion on how international collaboration can further transformative health breakthroughs. arpa-h.gov/engage-and-t...

What if a platform existed to help doctors make faster more accurate diagnoses? Register for the hybrid INDEX Proposers' Day on January 9. arpa-h.gov/research-and...

Are you heading to the 2025 J.P. Morgan Healthcare Conference? We are! 🙌 Join us in San Francisco to discuss how our streamlined business practices can help transform your innovative ideas into impactful health solutions. Express your interest in meeting by December 20: hubs.ly/Q02-MSH40

👏👏👏 Congrats to the team @cdi-ucsf.bsky.social! Our CT-NEURO project aims to develop cell-based therapies to deliver treatments to the brain, nervous system and other tissues, improving patient outcomes for hard-to-treat diseases, including glioblastoma, a deadly cancer. arpa-h.gov/news-and-eve...

Early career scientists and community leaders, our Emerging Health Innovators Initiative is here to help you bring your bold ideas to life! Check out the special notice: arpa-h.gov/engage-and-t...

What if we could cure blindness? Announcing the teams on our THEA program working to enable whole functional eye transplantation to restore vision for the blind and visually impaired. arpa-h.gov/news-and-eve...

What if we could make clinical trials accessible to most Americans? ACTR aims to create a clinical trial network that would enable 90% of eligible Americans to participate in clinical trials within 30 minutes of their home. arpa-h.gov/news-and-eve...

What if a platform existed to help doctors make faster, more accurate diagnoses? INDEX intends to create a high-quality medical imaging platform that does not currently exist to benefit the entire imaging ecosystem. arpa-h.gov/research-and...

What if we could predict drug safety and efficacy accurately before clinical trials even begin? 🚨 Hurry, Solution Summaries for CATALYST are due by 11/25 at 5:00 pm ET. arpa-h.gov/research-and...

What if women of any age could diagnose multiple infections by one inexpensive test at home? Glaucus will help address critical unmet challenges in women’s health for our #SprintForWomensHealth! 👏 arpa-h.gov/engage-and-t...